Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by DrHolidayon Jun 24, 2018 2:18pm
67 Views
Post# 28220776

RE:Buy more at 0.14 ? Short Sell or Hold longer ?

RE:Buy more at 0.14 ? Short Sell or Hold longer ?Excellent question.

I suggest you take your own advice and ride the rocket higher, and average down while it's on sale, RocketRyder.

More than the whole outstanding float changed hands recently which tells us that there is a brand new base of support which is being tested since volume spikes often retrace back to support.
I think we're there now because I saw Desjardins buying the dip @ 14 cents and we know that Oral B Amphotericin has shown no toxic side effects on test subjects.

Sharp traders who sold @ 20 cents and buying back in are redeploying capital to go long again.
The 94 million share volume traded recently doesn't even count previous volume spikes this year, so much of the stock in now concentrated into stronger hands.

DOC.
<< Previous
Bullboard Posts
Next >>